マテリアル事業

ホソカワミクロン株式会社 マテリアル事業本部

doi:10.24611/micromeritics.2024025

抄録

Material Business Division possesses advanced PLGA (Poly-Lactic-co-Glycolic Acid) nanoparticle technology with DDS (Drug Delivery System) characteristics. The PLGA nanocapsules proposed and provided by us have already been applied to not only drug formulations but also cosmetics, quasi-drugs, and medical devices such as stents and balloon catheters. Since 2004, we have launched to sell both a functional skincare cosmetic brand, “NanoCrysphere^®,” and a haircare brand, “NanoImpact^®,” utilizing PLGA nanocapsules. Currently, we are also promoting original design manufacturing (ODM) production and sales for various types of unique cosmetics, such as powdery serum and eyelash serum, etc., utilizing our PLGA nanocapsule technology.

著者関連情報

This article is licensed under a Creative Commons [Attribution 2.1 Japan] license.
https://creativecommons.org/licenses/by/2.1/jp/

お気に入り & アラート

閲覧履歴

発行機関からのお知らせ

<The 57th Symposium on Powder Technology will be held on September 3 at the TOKYO Garden Palace.>「第57回粉体工学に関する講演討論会」開催のお知らせ

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）